Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · 5-MeO-DMT (Bufo / Toad)

Is 5-MeO-DMT (Bufo / Toad) legal in United Arab Emirates?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
5-MeO-DMT is listed expressly in the tryptamines block of Schedule 5 of Decision No. 158 of 2025, at item 35, subitem 14. The entry is «5-MeO-DMT؛ 5-ميثوكسي-N,N-ثنائي ميثيل تريبتامين», and the dossier renders the chemical name as 2-(5-Methoxy-1H-indol-3-yl)-N,N-dimethylethanamine. The methoxy position is printed in the entry itself, which separates this row from the plain dimethyltryptamine entry carried elsewhere in the same schedule: the two are distinct enumerated substances and the placement of one is not evidence about the other. There is no plant or secretion limb in the entry, so what is controlled is the compound by name. Schedule 5 puts the row in the Articles 10, 41 and 57 branch, with a Schedule 10 group 1 quantity band. The placement was read on 20 September 2026.
Consequences if caught
Subitem 14 of the Schedule 5 tryptamines block sits in one of the four schedule groups Article 57 names. The dossier records the article as stating mandatory death for its trafficking or promotion trigger and as stating no quantity at all, so the capital route on this row attaches to the schedule rather than to an amount. Schedule 10 supplies a group 1 band for this substance and the dossier records that the bands do not gate Article 57, so the band describes something other than capital exposure. The row therefore cannot be answered with a weight in either direction, neither a figure above which death becomes available nor one below which it does not. Article 41 is the personal use route attached to this branch and the dossier does not state its tariff.
If prescribed or medical
The dossier's country level traveller material is a single record at the modafinil row: a 268 entry ministry travellers list checked and expressly not used as a schedule. Attached to this substance: 5-MeO-DMT is at Schedule 5, item 35, subitem 14, and the dossier carries no medicinal form, prescribing route or permit against that entry. The medical question is deferred here and not reasoned out from the branch or from the substance's research profile.
Documentation
No lawful carriage route is recorded for 5-MeO-DMT, so there is no document set to describe for this row. Provenance: the entry «5-MeO-DMT؛ 5-ميثوكسي-N,N-ثنائي ميثيل تريبتامين» at item 35, subitem 14 was read on 20 September 2026, and the capital analysis for the row rests on Article 57 and not on the Schedule 10 group 1 band. A traveller carrying anything said to contain this compound is outside what the dossier documents.
Primary sources
  • United Arab Emirates, Decision No. 158 of 2025, Schedule 5, item 35 (tryptamines), subitem 14, printed entry «5-MeO-DMT؛ 5-ميثوكسي-N,N-ثنائي ميثيل تريبتامين» for 5-MeO-DMT, a separate enumerated entry from the dimethyltryptamine entry in the same schedule
  • Articles 10, 41 and 57 attach to this branch and the Schedule 10 group 1 band does not gate Article 57
  • the schedule text was read at https://sha.shj.ae/#:~:text=5-MeO-DMT and the article text at https://uaelegislation.gov.ae/ar/legislations/1540#:~:text=%D8%A7%D9%84%D9%85%D8%A7%D8%AF%D8%A9%2057, the federal legislation portal
  • the instrument is written in Arabic and the English chemical rendering is the dossier's
  • read as at 20 September 2026

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in United Arab Emirates